Researchers continue to excited about the medication , a innovative dual agonist showing promising data in early trials for weight reduction . It acts by impacting both hormones : GLP-1 and GIP, these, https://theresaszon198602.ageeksblog.com/39254245/the-new-prospect-for-size-loss